Advanced in Triple-Negative Breast Cancer

Dr. Rachel E. Raab

Hematology Oncology | Hematology | Oncology
American Oncology Partners PA
551 Brevard Rd, 
Asheville, NC 
Accepting New Patients
Offers Telehealth
Advanced in Triple-Negative Breast Cancer
American Oncology Partners PA
551 Brevard Rd, 
Asheville, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Rachel Raab is a Hematologist Oncology specialist and a Hematologist in Asheville, North Carolina. Dr. Raab is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, HER-2 Positive Breast Cancer, Endometrial Cancer, and Bone Marrow Aspiration. Dr. Raab is currently accepting new patients.

Her clinical research consists of co-authoring 10 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has participated in 1 clinical trial in the study of Triple-Negative Breast Cancer.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in NC
Hospital Affiliations
Adventhealth Hendersonville
Memorial Mission Hospital And Asheville Surgery Ce
The Mcdowell Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
AmeriHealth
  • EPO
  • HMO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetLife
  • PPO
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

AMERICAN ONCOLOGY PARTNERS PA
551 Brevard Rd, Asheville, NC 28806

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Radiation, Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
A Randomized, Placebo-controlled, Double-blind, Multicenter Phase 2 Study of Atezolizumab With or Without Entinostat in Patients With Advanced Triple Negative Breast Cancer, With a Phase 1b Lead in Phase
A Randomized, Placebo-controlled, Double-blind, Multicenter Phase 2 Study of Atezolizumab With or Without Entinostat in Patients With Advanced Triple Negative Breast Cancer, With a Phase 1b Lead in Phase
Enrollment Status: Completed
Publish Date: December 04, 2024
Intervention Type: Drug
Study Drugs: Entinostat, Atezolizumab
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

10 Total Publications

Management of Cancer During Pregnancy: ASCO Guideline.
Management of Cancer During Pregnancy: ASCO Guideline.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 11, 2025
Similar Doctors
Advanced in Triple-Negative Breast Cancer
Dr. Steven W. Corso
Hematology Oncology | Hematology | Oncology
Advanced in Triple-Negative Breast Cancer
Dr. Steven W. Corso
Hematology Oncology | Hematology | Oncology

Spartanburg Medical Center

380 Serpentine Dr, Suite 200, 
Spartanburg, SC 
 (55.3 miles away)
864-560-7050
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Steven Corso is a Hematologist Oncology specialist and a Hematologist in Spartanburg, South Carolina. Dr. Corso is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Leukocytosis. Dr. Corso is currently accepting new patients.

Advanced in Triple-Negative Breast Cancer
Dr. Isaac E. Alwine
Hematology Oncology | Hematology | Oncology
Advanced in Triple-Negative Breast Cancer
Dr. Isaac E. Alwine
Hematology Oncology | Hematology | Oncology

Spartanburg Medical Center

101 E Wood St, 
Spartanburg, SC 
 (55.1 miles away)
864-560-1576
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Isaac Alwine is a Hematologist Oncology specialist and a Hematologist in Spartanburg, South Carolina. Dr. Alwine is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and HER-2 Positive Breast Cancer. Dr. Alwine is currently accepting new patients.

Advanced in Triple-Negative Breast Cancer
Dr. Dharmen J. Patel
Hematology | Oncology
Advanced in Triple-Negative Breast Cancer
Dr. Dharmen J. Patel
Hematology | Oncology

Tennessee Cancer Specialists

1301 Sunset Dr, Ste 3, 
Johnson City, TN 
 (54.8 miles away)
423-588-7130
Languages Spoken:
English
See accepted insurances
Offers Telehealth

. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Penile Cancer, Hemochromatosis, Non-Hodgkin Lymphoma, and Acute Mountain Sickness.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Raab's expertise for a condition
ConditionClose
    View All 70 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile